Evaluation of Index of Cardio-Electrophysiological Balance in Patients With Atrial Fibrillation on

Abdulmecit Afsin1, Ramazan Asoglu1, Mehmet Ali Kobat2

  • 1Department of Cardiology, Adiyaman Training and Research Hospital, Adiyaman, Turkey.

Cardiology Research
|January 15, 2021
PubMed

Insights

Amiodarone and propafenone affect the index of cardio-electrophysiological balance (iCEB) differently in atrial fibrillation (AF) patients. Propafenone showed lower iCEB values, suggesting potential differences in arrhythmia risk management.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Pharmacology

Background:

  • The index of cardio-electrophysiological balance (iCEB) is a novel risk marker for malignant ventricular arrhythmias.
  • Limited evidence exists on how amiodarone and propafenone impact iCEB in atrial fibrillation (AF) patients undergoing sinus rhythm maintenance.

Purpose of the Study:

  • To evaluate the index of cardio-electrophysiological balance (iCEB) in patients with atrial fibrillation (AF) treated with amiodarone or propafenone.

Main Methods:

  • 108 AF patients (68 on amiodarone, 40 on propafenone) and 50 controls underwent ECG.
  • Calculated QRS duration, QT, Tp-e intervals, iCEB (QT/QRS), and iCEBc (QTc/QRS) for comparison.

Main Results:

  • Amiodarone group showed longer QT, Tp-e intervals, and Tp-e/QT ratio compared to propafenone and controls.
  • iCEB was similar between amiodarone and control groups, but significantly lower in the propafenone group.
  • Heart rate-corrected iCEBc values differed significantly, being highest in the amiodarone group and lowest in the propafenone group.

Conclusions:

  • Amiodarone therapy was associated with higher iCEBc parameters, while propafenone was associated with the lowest iCEBc values in AF patients.
  • Further research is required to link these electrophysiological changes to ventricular arrhythmia risk in AF patients on antiarrhythmic drugs.
Abstract

Related Concept Videos

Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
201
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
2.3K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
1.1K
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
223
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
266
Dysrhythmias VII: Nursing Management of Dysrhythmias01:25

Dysrhythmias VII: Nursing Management of Dysrhythmias

Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
207